Trade Ideas October 14, 2026 05:28 AM

Zscaler: Re-rated Growth Stock — Time to Buy a Controlled Long with Tight Risk

AI security momentum and a clean balance sheet make ZS a sensible swing trade after a strong rerating; valuation and slowing growth cap upside but reward/risk is attractive.

By Nina Shah
Share
Twitter Reddit Facebook LinkedIn
ZS

Zscaler (ZS) has already seen a market re-rating this year on strong AI security traction and improving top-line momentum. The shares trade above key moving averages, institutional interest appears healthy and free cash flow is positive, but trailing multiples remain elevated. This trade idea targets a mid-term swing (45 trading days) long with defined entry, stop and target to capture continued multiple expansion or positive catalysts while limiting downside.

Zscaler: Re-rated Growth Stock — Time to Buy a Controlled Long with Tight Risk
ZS
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Zscaler has seen an earnings-driven re-rating thanks to AI-security bookings and 24.9% Q4 FY26 revenue growth.
  • Current price $228.74 sits above 10/20/50-day SMAs and momentum indicators are bullish, supporting a mid-term swing.
  • Trailing valuation is rich (P/S ~11.1x) but positive free cash flow ($852M) and manageable leverage justify a tactical long.
  • Trade plan: Long at $228.74, stop $205, target $275, horizon mid term (45 trading days) with ~2:1 reward-to-risk.

Hook & thesis

Zscaler (ZS) has already been re-rated by the market this year, driven by accelerating AI-security bookings and solid quarterly growth. The rally has left the shares well above short- and medium-term moving averages, but the business fundamentals and a healthy free cash flow profile justify a tactical long. This is not a buy-and-forget long-term punt; it is a controlled swing trade to capture further multiple expansion and follow-through from product momentum while keeping downside tightly capped.

My thesis: Zscaler's Zero Trust Exchange and nascent AI security stack are producing outsized bookings momentum (Security for AI bookings surged 50% sequentially in the latest quarter), which can sustain relative earnings revisions and push the stock higher in the coming weeks. At the same time, trailing valuation is elevated but nearer-term forward metrics and positive FCF provide a cushion. Trade with a clear entry, stop and target and treat this as a mid-term (45 trading days) swing.

Why the market should care - business and fundamental driver

Zscaler is a cloud-native security company providing Zero Trust internet and private access solutions. Its core products - Zscaler Internet Access, Zscaler Private Access, Client Connector and newer Cloud Protection and Security-for-AI offerings - are sold as subscription services to enterprises replacing appliance-based security stacks. That transition is structural: organizations want simpler, cloud-delivered security with better telemetry and lower operational overhead.

Why the market has re-rated Zscaler this year: the company reported a strong quarter with 24.9% revenue growth in Q4 FY26 and management highlighted Security-for-AI bookings up over 50% sequentially (this was a central message in reports on 10/08/2026). That kind of sequential acceleration in a strategic product category prompts multiple expansion, especially in cybersecurity where future product stickiness and cross-sell matter more than one-time hardware cycles.

Support from the numbers

  • Share price is trading at $228.74, above the 10-day SMA ($212.74), 20-day SMA ($207.55) and 50-day SMA ($188.76) - momentum is intact.
  • Trailing price-to-sales is about 11.1x and enterprise value to sales ~11.35x, reflecting a rich but not stratospheric multiple given the company's high-margin, recurring model and growth profile.
  • Free cash flow last reported $852.35M which translates into a price-to-free-cash-flow around 43.7x and a modest FCF yield near ~2-2.5% - positive but not generous; it still signals real cash conversion rather than a purely growth-at-all-cost story.
  • GAAP EPS is negative on a trailing basis (-$0.39), but consensus and coverage notes point to positive forward profitability implied by a forward P/E in coverage near ~43.5x, reflecting expectations of improving margins.
  • Balance sheet: debt-to-equity roughly 0.65 and current ratio ~1.7 - the company is not overlevered and has liquidity to invest in product development and go-to-market.

Valuation framing

On trailing metrics the valuation looks demanding: price-to-book roughly 14x and price-to-sales ~11x. However, two points matter for the near-term re-rating case:

  • Forward-looking metrics are more constructive. Analysts are modeling decelerating but solid growth (FY27 revenue growth consensus around mid-teens), and the market is already pricing in that transition — hence the forward P/S and forward P/E cited in coverage that are materially lower than trailing ratios.
  • Positive cash flow is real. FCF of $852M means the company generates operating cash that can fund product investment without immediate dilution; that helps justify a premium over legacy networking vendors.

In short, Zscaler is no longer an early-stage growth multiple: it is a growth-at-a-reasonable-price story where investors must balance continued execution on AI/security product adoption with an already-elevated multiple.

Technical backdrop

Momentum indicators favor the bulls: RSI sits near 67 and MACD shows bullish momentum with a positive histogram. Short interest has come down recently (settlement 9/30/2026 showed ~5.8M shares short), and short-volume prints have been meaningful on intraday bounces, suggesting some of the more speculative short activity has been neutralized.

Trade plan (actionable)

Direction: Long

Entry price: $228.74

Stop loss: $205.00

Target: $275.00

Horizon: mid term (45 trading days)

Rationale: Entry at $228.74 captures the current momentum post-re-rating. The stop at $205 protects from a failed breakout and roughly limits downside to ~10.4%. The initial target at $275 provides ~20% upside, a roughly 2:1 reward-to-risk ratio. The 45 trading day horizon allows time for earnings follow-through, analyst revisions, and further adoption evidence around AI security offerings to manifest.

Catalysts (near to mid term)

  • Quarterly earnings and guidance reaction - beats or raised guidance would likely trigger further multiple expansion.
  • Continued sequential acceleration in Security-for-AI bookings and cross-sell metrics - empirical proof that AI security becomes a durable revenue stream.
  • Analyst upgrades or target revisions following proof points on margins or bookings acceleration.
  • Broader sector momentum - cybersecurity leaders rallying together can lift ZS as investor risk appetite returns to growth names.

Risks and counterarguments

  • Valuation remains elevated. Trailing P/S ~11x and price-to-book >14x leave little margin for disappointment. If revenue growth slows faster than expected, the stock could give back a meaningful portion of the re-rating.
  • Growth deceleration risk. Consensus sees FY27 growth slowing to roughly the mid-teens from ~25% in FY26. If management confirms a steeper slowdown or lower customer add rates, catalyst momentum evaporates.
  • Competition and product execution. Palo Alto Networks, Fortinet and others are accelerating their AI-security offerings. Zscaler must maintain execution on product velocity and enterprise sales to hold gain share.
  • Margin/FCF compression. Recent notes point to rising capital spending and declining FCF margins despite positive dollar FCF. If margins deteriorate, valuations will compress quickly.
  • Macro/market risk. A risk-off move or tech rotation could disproportionately punish premium-growth software names even with solid company-level fundamentals.

Counterargument: The most plausible bearish view is that the market has already priced in the AI-security narrative and that decelerating organic growth combined with rising spend will erode margins, leaving limited upside. That is credible because Zscaler's trailing multiples are still rich and the timing of customer migrations to new AI security modules is uncertain.

What would change my mind

I would become more bullish if the company reports a clear continuation of 50%+ sequential growth in Security-for-AI bookings over multiple quarters, coupled with margin expansion or stable FCF margins. Conversely, I would reduce exposure or flip negative if the next quarterly report shows missed bookings targets, a material rise in churn, or guidance that meaningfully undercuts the current mid-teens growth expectation.

Conclusion - clear stance

ZS is a tactical long for a mid-term swing. The stock has already been re-rated on concrete product momentum, and the balance sheet and positive free cash flow justify paying up for growth. That said, valuation is not cheap and execution must continue to validate the AI-security narrative. This trade uses a disciplined entry ($228.74), a protective stop ($205), and a $275 target to capture further multiple expansion while maintaining defined risk.

Key data snapshot (for reference)

Metric Value
Current price $228.74
Market cap $38.6B
Trailing P/S ~11.1x
Free cash flow $852.35M
Q4 FY26 revenue growth 24.9%
Security-for-AI bookings (sequential) +50% (reported catalyst)

Trade idea summary: Long ZS at $228.74 with stop $205, target $275, mid-term horizon (45 trading days). Tight risk control is essential because the company has been re-rated and valuation leaves limited room for execution surprises.

Risks

  • High trailing valuation (P/S ~11.1x, price-to-book ~14x) leaves limited margin for execution misses.
  • Revenue growth likely to slow from FY26 levels; a sharper slowdown would pressure multiples and shares.
  • Competition from large incumbents rolling out AI-security products could erode pricing power or slow bookings.
  • Free cash flow margins are under pressure from rising capital spending; margin compression would hurt valuation.

More from Trade Ideas

BrightSpring: Improving Margins and Pharmacy Scale Make a 6‑ to 9‑Month Long Trade Attractive Oct 14, 2026 GOF: Deep Discount and a 24% Yield — Tactical Long with Defined Exit Oct 14, 2026 Amkor: Buy the CapEx-Fueled Reset — A 180-Day Long Trade Oct 14, 2026 FIGS: Growth, Margins and a Path to Re-Rating — A Long Trade Setup Oct 14, 2026 Nurix: Strong Buy - Roche Partnership and Bexobrutideg Data Point to Material Upside Oct 14, 2026